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Abstract: 
 
Effective and rapid dereplication is a hallmark of present-day drug discovery from natural 
sources. This project strove to both decrease the time and expand the structural diversity 
associated with dereplication methodologies. A 5 min liquid chromatographic run time 
employing heated electrospray ionization (HESI) was evaluated to determine whether it could be 
used as a faster alternative over the 10 min ESI method we reported previously. Results revealed 
that the 5 min method was as sensitive as the 10 min method and, obviously, was twice as fast. 
To facilitate dereplication, the retention times, UV absorption maxima, full-scan HRMS and 
MS/MS were cross-referenced with an in-house database of over 300 fungal secondary 
metabolites. However, this strategy was dependent upon the makeup of the screening in-house 
database. Thus, mass defect filtering (MDF) was explored as an additional targeted screening 
strategy to permit identification of structurally related components. The use of a dereplication 
platform incorporating the 5 min chromatographic method together with MDF facilitated rapid 
and effective identification of known compounds and detection of structurally related analogs in 
extracts of fungal cultures. 
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Enhanced dereplication of fungal cultures via
use of mass defect filtering
Noemi D Paguigan1, Tamam El-Elimat1, Diana Kao1, Huzefa A Raja1, Cedric J Pearce2
and Nicholas H Oberlies1
Effective and rapid dereplication is a hallmark of present-day drug discovery from natural sources. This project strove
to both decrease the time and expand the structural diversity associated with dereplication methodologies. A 5 min liquid
chromatographic run time employing heated electrospray ionization (HESI) was evaluated to determine whether it could be
used as a faster alternative over the 10 min ESI method we reported previously. Results revealed that the 5 min method was as
sensitive as the 10 min method and, obviously, was twice as fast. To facilitate dereplication, the retention times, UV absorption
maxima, full-scan HRMS and MS/MS were cross-referenced with an in-house database of over 300 fungal secondary
metabolites. However, this strategy was dependent upon the makeup of the screening in-house database. Thus, mass defect
filtering (MDF) was explored as an additional targeted screening strategy to permit identification of structurally related
components. The use of a dereplication platform incorporating the 5 min chromatographic method together with MDF facilitated
rapid and effective identification of known compounds and detection of structurally related analogs in extracts of fungal cultures.
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INTRODUCTION
As Ōmura and colleagues1 showed the world via their research on
avermectins1–3 (and many other compounds), nature is a prolific
source of chemical diversity, providing humanity with many drugs and
drug leads for a suite of diseases.4–7 A common characteristic
of natural product extracts is that they consist of a mixture of
compounds, often structurally related, although present at varying
abundance. As such, it is desirable to have a means to prioritize
samples, such that valuable time and financial resources can be
focused on those extracts most likely to yield new structural diversity.
An important part of this discovery process involves dereplication, a
rapid identification of known compounds in extracts in order to focus
on the isolation of new chemical entities. Several recent advancements
in dereplication strategies, most involving hyphenated spectroscopic
techniques, have been pivotal to the increased efficiency in natural
product-based drug discovery.8–10 In particular, MS coupled with
electrospray ionization (ESI) has become increasingly more important
in natural product drug discovery, especially for chemical profiling of
complex extracts.11–13 Hyphenation of liquid chromatography with
ESI-MS has increased the pace of dereplication by providing an
efficient means of identifying the multiple components of complex
extracts before further purification and isolation work.10,14
Our research team has been working on the dereplication of fungal
cultures for about a decade, particularly within a drug discovery
program that aims to identify new anticancer lead compounds.15,16
This started with a generalized dereplication methodology utilizing UV
and 1H NMR spectra and targeting distinct classes of mycotoxins,17 as
these nuisance compounds yield positive results in cytotoxicity-based
assays. This protocol evolved significantly to target a wider range of
secondary metabolites in fungal extracts using a complementary suite
of hyphenated techniques, specifically ultraperformance liquid
chromatography-photodiode array-high resolution tandem mass spec-
trometry (UPLC-PDA-HRMS-MS/MS). Finally, the latter was aug-
mented with a droplet liquid microjunction surface sampling probe so
as to analyze the secondary metabolite profile of fungal cultures
in situ.18
Mass defect filtering (MDF) was developed recently and is finding
growing use in drug metabolite profiling studies.19–21 This approach
utilizes the full-scan HRMS data, and detection of drug metabolites is
accomplished via data mining after acquisition. MDF is based on the
fact that each isotope of every element has a defined mass defect
(that is, the nonintegral portion of an m/z value). This is why each
molecule of a defined elemental composition will have a unique exact
mass, typically observed in the 1000ths to 10 000ths place.
The useful application of MDF in drug metabolism studies is
centered on the observation that the core structure of a drug does not
change significantly during biotransformation.19,22,23 Thus, the mass
defect between the parent drug and its metabolites will fall within a
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narrow range (typically within 50 mDa). If a mass defect filter window
is centered on the mass defect of the parent drug, then ions with a
mass defect outside of this window will be excluded, resulting in the
removal of interference signals in the total ion chromatogram.
Importantly, this then facilitates the selective identification of drug
metabolite peaks from the noise in complex biological matrices.
Aside from drug metabolite identification, MDF has been adapted
for use in the qualitative examination of natural products, particularly
those based on herbals.24–26 However, this data-mining tool has not
been used in the analysis of fungal secondary metabolites. Theoreti-
cally, compounds produced by fungi can be classified into distinct
classes, each class sharing the same core structure. Thus, if a filter
reference and substituents around the core structure are carefully
defined, then mass defect filters can be constructed to exclude the
majority of unrelated ions. This should, in turn, facilitate the
identification of structural analogs in the extract.
In this study, MDF is presented as an additional approach for the
targeted screening of secondary metabolites in fungal extracts.
The merger of UPLC-PDA-HRMS-MS/MS dereplication with MDF
permits additional profiling for structurally related components in the
sample based on their mass defects (Scheme 1). This workflow
enhances the dereplication methods so as to screen for a wider range
of secondary metabolites produced by fungal cultures.
RESULTS AND DISCUSSION
The 5 min HESI method
Previously, we developed a dereplication method for diverse classes of
fungal secondary metabolites16 in extracts on an LTQ Orbitrap.27 That
protocol utilized a 10 min liquid chromatographic run time to acquire
full-scan HRMS and MS/MS (using a normalized collision energy
of 30) spectra in both positive and negative ESI modes, with UV
absorption maxima and retention times used as orthogonal data. To
Scheme 1 Proposed workflow for dereplication of fungal extracts including a 5 min ultraperformance liquid chromatography-photodiode array-high resolution
tandem mass spectrometry (UPLC-PDA-HRMS-MS/MS) methodology. HRMS and MS/MS (collision-induced dissociation (CID) 30) data were acquired by LTQ
Orbitrap using data-dependent scan. A postacquisition data analysis using IntelliXtract, an add-in feature of ACD MS Manager, cross-references the molecular
ion peaks and retention times to identify compounds known to the in-house database. For targeted analysis of a specific class of compounds, a user-defined
mass defect filtering criterion was designed based on accurate masses and mass defects centered around a core structure. The HRMS data were filtered with
Compound Discoverer software to identify components related to the known compounds. The identity of the known compounds were verified based on HRMS,
MS/MS fragmentation pattern, retention time and UV absorption maxima. The tentative identity of the discovered unknown compounds were assigned based
on the interpretation of their CID-MS/MS (30 eV) fragmentation patterns.
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facilitate dereplication, these data were uploaded into ACD MS
Manager with add-in Intelliextract software that cross-references the
molecular ion peaks and retention times with an in-house database of
over 300 fungal secondary metabolites. Molecular ions identified by
the software that matched the database were confirmed by comparison
of the HRMS, MS/MS, retention time and UV data to that of the
standard in the database. With this method, nearly all of the fungal
metabolites (498%) in the in-house database ionized efficiently in the
ESI+ mode, whereas ∼ 90% of the samples ionized in the ESI− mode.
In total, this suggested the ESI+ mode as the ionization of choice for
sample dereplication, unless knowledge of the samples or extracts
indicated ionization in ESI− mode.
Although valuable for routine analysis of a large number of samples
(batches of450 samples), the 10 min liquid chromatographic method
was not ideal, particularly for shared instruments. Thus, a dereplica-
tion method utilizing a 5 min run time at a 0.6 ml min− 1 flow rate via
heated electrospray ionization (HESI) was evaluated to determine
whether it could be used as a faster alternative. The use of HESI was
important,28,29 as it would allow better desolvation, given that a higher
flow rate (twice as fast) was used for the 5 min method compared with
the 0.3 ml min− 1 flow rate utilized in the 10 min method.
As proof of concept, about a third of the fungal library (4100
compounds) was analyzed in the HESI+ using the 5 min method to
obtain the retention times, UV absorption maxima, full-scan HRMS
and MS/MS spectra. In general, data obtained for all compounds
matched with data in the database built using the 10 min dereplication
method,27 except for the retention times.
To compare the performance characteristics of the 10 min ESI
dereplication method with the 5 min HESI dereplication, the two
related parameters, limit of detection (LOD) and limit of quantitation
(LOQ), were measured for each method, both in the positive
ionization mode. The LOD and LOQ values were obtained from the
calibration data and regression line directly (Supplementary Figures S1
and S2). Five representative compounds (1–5) were tested that had
molecular weights ranging from 373 to 1963 amu, and this included
compounds that were based on polyketide building blocks, amino acid
building blocks and those with both in their scaffolds (Supplementary
Table S1). In general, the 5 min HESI method had comparable
sensitivity to the 10 min ESI method based on the LOD and LOQ
values obtained for the five analytes tested (Supplementary Table S1).
Dereplication of fungal extracts
An extract of MSX40080 was dereplicated and determined to contain
aflatoxins, thus explaining its potent cytotoxicity.27 To test whether the
5 min method would be able to identify the same aflatoxins, the
extract was reanalyzed (Figure 1). Five aflatoxins, including sterigma-
tocystin (6), 5-methoxysterigmatocystin (7), aversin (8), brevianamide
P (9) and 6,8-di-O-methyl averufin (10), were identified, consistent
with previous results.27 Comparison of data obtained from both
methods indicated that only the retention times were different
for the detected compounds, as shown for 6 (Figure 2) and 7–10
(Supplementary Figure S3). In the context of discovering leads for an
anticancer drug discovery program, aflatoxins are an obvious nuisance,
making their rapid dereplication critical.
Dereplication using UPLC-PDA-HRMS-MS/MS with MDF
The first step of the dereplication strategy was focused on the targeted
screening of secondary metabolites in our library using the 5 min
UPLC-HRMS-MS/MS methodology. To take this dereplication strat-
egy a step further, identified hits were expanded upon by screening for
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Figure 1 (a) The (+)-ESI-TIC of MSX40080. (b) The selected ion chromatogram (SIC) of dereplicated aflatoxins (6–10) in MSX40080. ESI, electrospray
ionization; TIC, total ion chromatogram.
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potential analogs with the aid of Compound Discoverer data-
processing software utilizing MDF. MDF was essential to remove
the majority of interfering ions and facilitate detection of the potential
structural class of related compounds via post acquisition processing
of HRMS data. Theoretically, each structural analog possessed
relatively minor and well-defined changes in the mass defect from
filter reference compounds. Therefore, the mass defects between the
reference skeletons and related analogs should fall within a defined
mass defect window.
The case of identifying epipolythiodioxopiperazine (ETP) alkaloid
analogs in different fungal cultures illustrates the use of the
UPLC-PDA-HRMS-MS/MS dereplication strategy and the benefits of
MDF. Recent studies have identified verticillin A (11) as an effective
tumor suppressor, inducing tumor cell apoptosis in metastatic human
colorectal cancer cells at nanomolar concentrations,30,31 and structu-
rally related analogs have been shown to have potent biological
activities.32–34 Therefore, it was valuable to identify these compounds
in extracts, and at the same time determine the presence of structurally
related analogs that were not part of our library. In this case we were
using dereplication as a means to identify other fungi that biosynthe-
size these compounds, with the aim of enhancing scale-up and
production, as will be reported in the future.
A common characteristic of the 15 analogs, all being dimeric ETPs,
is a polysulfide bridge in the molecule (Dictionary of Natural
Products, Taylor and Francis Group, Oxford, UK). Supplementary
Figure S4 is a graphical representation of the accurate masses and the
corresponding mass defects of these compounds. As summarized in
Supplementary Table S2, the compounds fall into a narrow range of
nominal masses and mass defects. To identify these analogs, a filtering
template was set using the structure of Sch 52901 (12) having a
nominal mass that is the midpoint of the target compounds, and
setting a mass window of ± 150 Da. The analogs show a narrow
range of mass shifts as a result of modifications in the structures,
yielding only a small difference in mass defects relative to the template
core structure 12 (Supplementary Table S2). Using a slightly
wider mass defect range covering all the potential target compounds
(Supplementary Table S2), a mass defect window of ± 50 mDa was
implemented.
The applicability of MDF for detecting these analogs was illustrated
with the analysis of an extract obtained from a culture of Clonostachys
rogersoniana (MSX59553) that was previously identified by our
research group as a Bionectriaceae sp. (Hypocreales) based on partial
28S rDNA sequence data (JQ749725) and was known to biosynthesize
ETP alkaloids.34 Dereplication of this strain using the 5 min HESI+
method identified six known ETPs, including verticillin A (11), Sch
52901 (12), verticillin H (13), 11′-deoxyverticillin (14), Sch 52900
(15), and gliocladicillin C (16) based on retention times, HRMS and
MS/MS data (Figure 3 and Supplementary Figure S5). The total ion
chromatogram of MSX59553 was analyzed further by MDF with the
aim of revealing additional structurally related analogs. MDF
significantly reduced the amount of interfering ions (Supplementary
Figure S6), facilitating identification of related analogs that were
present in the extract. The characteristic peaks of ETPs captured by
MDF was consistent with the verticillins identified in the previous
analysis.
Identification of the fragmentation pattern for ETP alkaloids
The benefit of using MDF in conjunction with the traditional targeted
dereplication strategy is that it gives additional insight into the
remaining unknown compounds present in the extract by simplifying
the data. Once a potential structurally related compound based on
mass defect is identified, its structure must be confirmed. However,
with the absence of a standard, this might be a challenging task. Thus,
to facilitate characterization within the context of an extract, the
characteristic collision-induced dissociation (CID) fragmentation can
be analyzed to tentatively assign a structure. In the literature, several
studies have been reported that use a CID-MS/MS-based workflow for
structural elucidation of natural products.35–37 Implementation of this
strategy requires knowledge of the fragmentation patterns of com-
pounds in the same structural class.
Compounds having the same core substructure generally exhibit
similar mass fragmentation patterns, and thus can be identified based
on their diagnostic fragment ions.26 For the case of ETP alkaloids,
the recurrent fragmentation pattern was characterized based on the
MS/MS CID fragmentation taken in positive mode (Supplementary
Figure S5). In general, desulfurization of the precursor ion peak
Figure 2 Comparison of SIC (m/z 325), (+)-HRMS, CID MS/MS (30 eV) and UPLC-PDA data of sterigmatocystin (6) detected in MSX40080 using (a) the
5 min and (b) the 10 min dereplication protocols. CID, collision-induced dissociation; PDA, photodiode array; SIC, selected ion chromatogram;
UPLC, ultraperformance liquid chromatography.
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([M-2S+H]+, arising from the polysulfide bridge in each of the
dioxopiperazine rings, were observed in all CID-MS/MS analyses.
Nearly all compounds exhibited dehydration of the [M-2S+H]+ ion,
whereas the compound 11′-deoxyverticillin A (14), which possessed
one hydroxy group, did not. This may indicate that the removal of a
H2O was dependent on the number of hydroxy moieties in the
compounds. After H2O loss, a fragment peak, indicating loss of one of
the dioxopiperazine moieties was observed. For instance, in verticillin
A, the fragment peak at m/z 615.18 was followed by a peak at
m/z 465.08, corresponding to a difference of 150 Da and accounting
for the loss of a dioxopiperazine moiety (C7H6N2O2). After this
observed dissociation, dehydration and desulfurization occurred, most
likely in the other dioxopiperazine moiety of the core.
With the examination of the CID diagnostic fragment ions of the
ETP standards (Supplementary Figure S5), we sought to apply this to
the rapid characterization of analogs of the ETPs in other complex
mixtures, where laboratory reference standards were not available.
Analysis of verticillin production in G35
A culture of Colletotrichum fioriniae (G35) was identified previously by
dereplication to produce 11 and 15.38 However, refermentation of the
culture using the standard rice culture conditions failed to produce
any structurally related analogs. In order to revive the ETP biosyn-
thetic pathway, the OSMAC (one strain-many compounds) approach
was applied.39 Using this strategy, 12 separate growth conditions
providing different nutrients were tested to identify the most favorable
condition that would lead to the revival of the biosynthetic pathway.
Still, no analogs were dereplicated in any of the extracts.
Upon analysis of the HRMS data with MDF, a culture of G35 grown
in oatmeal agar (Difco, Sparks, MD, USA) showed a peak that had a
corresponding value at m/z 757.1212 that matched the monoisotopic
mass of protonated verticillin D (17) with +3.3 ppm mass accuracy
(Figure 4). The peak with m/z 757.1212 was identified as an ETP
alkaloid based on comparison of the characteristic losses observed in
its MS/MS spectrum (Figure 4), exhibiting a distinctive fragmentation
Figure 3 The (+)-ESI-TIC of MSX59553 and epipolythiodioxopiperazine analogs (11–16) dereplicated via the 5 min UPLC-PDA-HRMS-MS/MS (CID 30 eV)
method. CID, collision-induced dissociation; ESI, electrospray ionization; PDA, photodiode array; SIC, selected ion chromatogram; TIC, total ion
chromatogram; UPLC, ultraperformance liquid chromatography.
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pattern similar to that of verticillin A (Supplementary Figure S5). In
particular, the fragment ions at m/z 693.11 and m/z 675.10 indicated
desulfurization and dehydration, respectively.
Coincidentally, 17 was isolated from a fungal culture of a
Clonostachys sp. (G600), and this presented an opportunity to
verify the identity of the peak observed in G35. The HRMS
and MS/MS data for 17 were analyzed and matched that of the
compound with m/z 757.1212 from G35 (Figure 4). This
result verified that 17 was indeed being produced in low quantities
by G35 in oatmeal agar, an observation that would not be possible
without MDF.
This result demonstrated the advantages of incorporating MDF as a
processing technique in the dereplication platform. Verticillin D (17)
was not part of the database when the samples were dereplicated and
processed originally. As MDF is a post acquisition data mining
technique that analyzes solely the HRMS data, samples can be
reevaluated as more data become available.
Co-culture analysis using dereplication with MDF
Analysis of the extract of G600 and a strain of Lindgomyces
madisonensis (G416) grown in co-culture illustrates the use of
dereplication with MDF to determine the production of induced
secondary metabolites. In this case, the goal was to determine the
presence of structurally related ETPs in the extract. As mentioned
previously, G600 was determined to biosynthesize 17; G416, on
the other hand, was known to produce mainly polyketides.40 The
co-culture was analyzed, and the resulting mass defect profile was
compared with separate cultures of G600 and G416 (Figure 5). As
expected, 17 was identified and appeared to be the most abundant in
both G600 and the co-culture (Supplementary Figure S7). Further
inspection of the mass defect profile of the cultures indicated that the
co-culture had a peak at m/z 755.1062 that was not detected in a
monoculture of G600. The accurate mass for the detected molecular
ion peak matched that of verticillin F (18), a dimeric ETP alkaloid, at
− 3.0 ppm mass accuracy (Figure 6). The MS/MS fragmentation
for the peak indicated desulfurization of the precursor ion peak
(m/z 690.16), followed by dehydration (m/z 673.03), possible loss of
one of the dioxopiperazine moieties (m/z 495.01) and then desulfur-
ization and dehydration (m/z 413.22), all consistent with the
distinctive dissociation of ETPs (Figure 6). Based on this observation,
the molecular ion peak identified could be tentatively assigned as
verticillin F (18), even in the absence of a standard for confirmation.
Interestingly, the mass defect profile for a monoculture of G416
exhibited a peak at m/z 683.1545. However, the MS/MS profile for that
peak did not display the characteristic pattern indicative of an ETP
alkaloid (Supplementary Figure S8). This suggested that the detected
peak was a false positive and illustrates how MS/MS data can be used
to either verify or refute potential hits.
CONCLUSION
A method to dereplicate fungal extracts was further optimized. This
methodology improves a previous dereplication strategy by combining
two schemes: (1) targeted screening of compounds known to an
in-house built database using a 5 min UPLC-PDA-HRMS-MS/MS
where HESI was utilized and ACD/IntelliXtract software to facilitate
the dereplication; (2) MDF of resulting accurate mass full-scan raw
data for a targeted identification of selected known natural products.
In particular, MDF is a data-mining technique that can be applied
after acquisition, permitting the reevaluation of data when future
compounds of interest are identified.
EXPERIMENTAL PROCEDURE
Fungal samples
All fungal samples used in this study were from either the Mycosynthetix
(MSX) culture collection (Hillsborough, NC, USA) or the University of North
Carolina at Greensboro, Department of Chemistry and Biochemistry, Fungal
Culture Collection (Greensboro, NC, USA).
Isolation and identification of fungal strains
Dr Barry Katz isolated Mycosynthetix fungal strain MSX59553 in January
1992 from leaf litter,34 whereas strain MSX40080 was isolated from oak leaf
litter in September 1988. Strain G600 was isolated from submerged wood
from fresh water in Knight-Brown Nature Preserve in North Carolina,
USA (N 36 18.861′, W 80 0.423′). Strain G35 was isolated and identified
from surface sterilized seeds of Hydrastis canadensis (goldenseal) as
Colletotrichum fioriniae (KX110401).38 In addition to examining the
micromorphological characteristics, for molecular identification of new
strains dereplicated in the present study (MSX59553 and G600), the internal
transcribed spacer region of the nuclear RNA operon was sequenced and
analyzed via BLAST search (National Center for Biotechnology Information,
Bethesda, MD, USA). In addition, we constructed a Maximum Likelihood
phylogenetic tree by incorporating internal transcribed spacer sequences
from the newly sequenced strains along with internal transcribed spacer
sequences used in a recent study on molecular identification
of Clonostachys spp41 based on the outcome of results from BLAST
search. Methods for sequencing of the strains, BLAST search and Maximum
Figure 4 Detection of verticillin D (17) in G35 grown in oatmeal agar after mass defect filtering. (a) Overlay of (+)-ESI-TIC of 17. (b) CID MS/MS (30 eV)
spectra of 17. CID, collision-induced dissociation; ESI, electrospray ionization; TIC, total ion chromatogram.
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Likelihood phylogenetic analysis have been summarized previously.42–45
Based on morphological and molecular data, MSX59553 was identified as
Clonostachys rogersoniana,46 as it occurred in a strongly supported clade
(99% PHYML bootstrap support) with other sequences of C. rogersoniana,
including a reference strain (CBS 582.89). Culture G600 was identified as
Clonostachys sp. The Maximum Likelihood tree along with micromorpho-
logical characters of the newly sequenced strains are presented in
Supplementary Figures S9 and S10. The newly obtained sequences from
Figure 5 Analysis of the extract of G600 and G416 grown alone and in co-culture using dereplication with mass defect filtering to determine the production
of induced secondary metabolites. (a) Overlay of (+)-ESI-TIC of the samples. (b) Overlay of (+)-ESI-TIC of the samples after mass defect filtering.
ESI, electrospray ionization; TIC, total ion chromatogram.
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this study have been deposited in GenBank (accession no. KX845687 and
KX845688, respectively).
Fermentation and extraction of fungal cultures
Fungal cultures were grown as described previously.34,47,48 Once the screener
cultures were generated, 60 ml of 1:1 CH3OH-CHCl3 was added into each flask,
followed by shaking for ∼ 16 h at room temperature on an orbital shaker set at
∼ 100 r.p.m. The resulting mixtures were filtered under vacuum. To the filtrate,
90 ml of CHCl3 and 150 ml of H2O were added, and the mixture was stirred
for 30 min and then transferred into a separatory funnel. The bottom layers
were drawn off and dried in vacuo. The dried organic extracts were defatted by
reconstituting in a mixture of 100 ml of 1:1 CH3OH-CH3CN and 100 ml of
hexane, and then partitioned. The CH3OH-CH3CN layers were collected and
concentrated in vacuo.
For G35, from the seed culture, an inoculum was transferred onto five
100 mm×15 mm Petri dishes with solid oatmeal agar (Difco) mix. The
cultures were then allowed to grow for 28 days at room temperature before
they were extracted. Extraction of these samples were performed in the same
way as the screener cultures.
UPLC-PDA-HRMS-MS/MS
Fungal extracts were dissolved with CH3OH-dioxane (1:1, v/v) to obtain a final
concentration of 2 mg ml− 1. UPLC-HESI-HRMS-MS/MS was performed on
an Acquity UPLC system (Waters, Milford, MA, USA) equipped with a cooled
autosampler kept at 10 °C, photodiode array detector (PDA), column manager
and binary solvent manager, all coupled to an LTQ-Orbitrap XL mass
spectrometry system (Thermo Finnigan, San Jose, CA, USA) with HESI.
UPLC separations were performed at 40 °C on a 50 mm×2.1 mm i.d.,
1.7 μm, Acquity BEH C18 column (Waters) equipped with a security guard
precolumn. A linear CH3CN-H2O gradient of 15% CH3CN-H2O to 100%
CH3CN in 4 min was applied at a constant flow rate of 0.6 ml min
− 1; then
100% CH3CN was maintained for 0.75 min before returning to the starting
conditions in 0.25 min. All solvents used were acidified with 0.1% formic acid.
PDA data were collected from 191 to 499 nm with resolution of 3.6 nm at a
5 point per s sampling rate.
The HESI source was operated in the positive ionization mode with the
following conditions: vaporizer temperature set at 300 °C; capillary temperature
set at 275 °C; 4.0 kV for the source voltage; 9.0 V for the capillary voltage; and
100.0 V for the tube lens; Nitrogen sheath gas flow rate set at 35.00 arb.
Full-scan HRMS data were acquired from m/z 100 to 2000. A CID energy of
30 eV in the ion trap was used to obtain MS/MS fragmentation data. The
system was controlled with Thermo Xcalibur software version 2.2 (Thermo-
Fisher Scientific, San Jose, CA, USA).
The LC-MS raw data were processed by the add-in IntelliXtract feature of the
ACD MS Manager (Advanced Chemistry Developments, Toronto, ON,
Canada). MDF of the HRMS data was performed with Thermo Scientific
Compound Discoverer software version 1.0 (Thermo Scientific, San Jose,
CA, USA).
LOD and LOQ data analysis
Calibration curves were obtained by preparing twofold serial dilutions of the
standards that were analyzed in triplicate via 3 μl injections. All LC-HRMS data
were processed using Thermo Xcalibur to automatically integrate and calculate
the MS signal peak area of each analyte over noise. Linearity of the calibration
curves was assessed by least-squares analysis. The concentration of the
analyte that gives the LOD (CLOD) and the concentration at LOQ (CLOQ)
were calculated as 3 times the s.e. of the regression line (sy/x) divided by the
slope (b) and 10 times sy/x divided by b, respectively. The standards, alamethicin
F50 (1), trichokonin VI (2), equisetin (3), acremonidin A (4) and acuminatum
B (5), were dissolved separately in a 1:1 CH3CN-dioxane mixture to produce a
15 726 μM stock solution of each. An aliquot from each standard solution was
taken to prepare a 2621 μM multi-standard stock solution. A twofold serial
dilution of the multistandard stock solution was prepared to make 20 standard
solutions at concentrations ranging from 0.0025 to 1310 μM.
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